Gait Speed in Spinal Muscular Atrophy: A Key Vital Sign Linked to Strength and Fatigability
ABSTRACT Introduction/Aims Gait Speed (GS), a valid and reliable indicator of function and health in multiple populations, has not been explored in spinal muscular atrophy (SMA). The purpose of this study was to characterize GS and gait speed reserves (GSR), and explore associations with strength and fatigability in SMA and healthy controls (HC). Methods Data were collected from ambulatory individuals with SMA ( n = 14) and controls (HC) ( n = 10). Using custom‐engineered instrumented insoles, stride velocity (SV) was collected during the Six‐Minute Walk Test (6MWT) and 10‐m walk/run (10MWR). Three GS variables were identified; SV50th Centile 6MWT (SV50C 6MWT ), 10MWR SV, and SV95th Centile 6MWT (SV95C 6MWT ). Gait speed reserve (GSR) was calculated from 10MWR and SV50C 6MWT . Repeated measures analysis of variance assessed differences in GS and GSR across groups. Spearman's Rho was used to assess associations between speed variables and clinical assessments. Results All speed variables were different within HC ( p < 0.001) and SMA ( p = 0.002). There was a significant Group × Speed interaction ( p < 0.001) with greater differences in HC. GSR was lower in SMA ( p < 0.001, d = 2.42). In SMA, thigh strength was associated with all three GS variables and inversely associated with fatigability ( p < 0.05). In HC, associations between GS and strength or fatigability were not observed. GSR was not associated with strength, fatigability, or GS in either group. Discussion GS is diminished in SMA and correlated with strength and fatigability. While reduced in SMA, GSR was not associated with GS, strength, or function. GS is a key vital sign of health and may be a useful biomarker in SMA.
Authors
- E. HARDING (ORCID: https://orcid.org/0000-0002-0004-6960)
- Jacqueline Montes (ORCID: https://orcid.org/0000-0002-7357-0819)
- Sally Dunaway Young (ORCID: https://orcid.org/0000-0001-9322-0608)
- Maria A. Fragala-Pinkham (ORCID: https://orcid.org/0000-0001-7634-7519)
- Rabia Farooquee (ORCID: https://orcid.org/0009-0003-3631-006X)
- Rafael Rodriguez‐Torres (ORCID: https://orcid.org/0009-0005-3648-0741)
- Ton T. H. Duong (ORCID: https://orcid.org/0000-0002-2529-5875)
- C. de Monts (ORCID: https://orcid.org/0009-0004-7659-8069)
- Damiano Zanotto (ORCID: https://orcid.org/0000-0003-3514-6889)
- Cara Yochai (ORCID: https://orcid.org/0000-0002-1414-6890)
- Amy Pasternak
- Carly Magun (ORCID: https://orcid.org/0009-0003-6612-6634)
Institutions
- Stevens Institute of Technology (US)
- Boston Children's Hospital (US)
- Columbia University Irving Medical Center (US)
- Stanford Medicine (US)
- Stanford University (US)
Publication Details
- Journal
- Muscle & Nerve
- Published
- 2026-09-12
- DOI
- https://doi.org/10.1002/mus.70380
- Primary Topic
- Neurogenetic and Muscular Disorders Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Science Foundation
- Muscular Dystrophy Association
- State of New Jersey Department of Health
- Cure SMA
- Division of Chemical, Bioengineering, Environmental, and Transport Systems